Cargando…
Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
Since the start of the coronavirus disease 2019 (COVID‐19) pandemic, new variants of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) have emerged, accelerating the spread of the virus. Omicron was defined by the World Health Organization in November 2021 as the fifth “variant of concern...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380698/ https://www.ncbi.nlm.nih.gov/pubmed/35992968 http://dx.doi.org/10.1002/mco2.172 |
_version_ | 1784768929827127296 |
---|---|
author | Xu, Ailan Hong, Bixia Lou, Fuxing Wang, Shuqi Li, Wenye Shafqat, Amna An, Xiaoping Zhao, Yunwei Song, Lihua Tong, Yigang Fan, Huahao |
author_facet | Xu, Ailan Hong, Bixia Lou, Fuxing Wang, Shuqi Li, Wenye Shafqat, Amna An, Xiaoping Zhao, Yunwei Song, Lihua Tong, Yigang Fan, Huahao |
author_sort | Xu, Ailan |
collection | PubMed |
description | Since the start of the coronavirus disease 2019 (COVID‐19) pandemic, new variants of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) have emerged, accelerating the spread of the virus. Omicron was defined by the World Health Organization in November 2021 as the fifth “variant of concern” after Alpha, Beta, Gamma, and Delta. In recent months, Omicron has become the main epidemic strain. Studies have shown that Omicron carries more mutations than Alpha, Beta, Gamma, Delta, and wild‐type, facilitating immune escape and accelerating its transmission. This review focuses on the Omicron variant's origin, transmission, main biological features, subvariants, mutations, immune escape, vaccination, and detection methods. We also discuss the appropriate preventive and therapeutic measures that should be taken to address the new challenges posed by the Omicron variant. This review is valuable to guide the surveillance, prevention, and development of vaccines and other therapies for Omicron variants. It is desirable to develop a more efficient vaccine against the Omicron variant and take more effective measures to constrain the spread of the epidemic and promote public health. |
format | Online Article Text |
id | pubmed-9380698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93806982022-08-19 Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention Xu, Ailan Hong, Bixia Lou, Fuxing Wang, Shuqi Li, Wenye Shafqat, Amna An, Xiaoping Zhao, Yunwei Song, Lihua Tong, Yigang Fan, Huahao MedComm (2020) Reviews Since the start of the coronavirus disease 2019 (COVID‐19) pandemic, new variants of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) have emerged, accelerating the spread of the virus. Omicron was defined by the World Health Organization in November 2021 as the fifth “variant of concern” after Alpha, Beta, Gamma, and Delta. In recent months, Omicron has become the main epidemic strain. Studies have shown that Omicron carries more mutations than Alpha, Beta, Gamma, Delta, and wild‐type, facilitating immune escape and accelerating its transmission. This review focuses on the Omicron variant's origin, transmission, main biological features, subvariants, mutations, immune escape, vaccination, and detection methods. We also discuss the appropriate preventive and therapeutic measures that should be taken to address the new challenges posed by the Omicron variant. This review is valuable to guide the surveillance, prevention, and development of vaccines and other therapies for Omicron variants. It is desirable to develop a more efficient vaccine against the Omicron variant and take more effective measures to constrain the spread of the epidemic and promote public health. John Wiley and Sons Inc. 2022-08-16 /pmc/articles/PMC9380698/ /pubmed/35992968 http://dx.doi.org/10.1002/mco2.172 Text en © 2022 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Xu, Ailan Hong, Bixia Lou, Fuxing Wang, Shuqi Li, Wenye Shafqat, Amna An, Xiaoping Zhao, Yunwei Song, Lihua Tong, Yigang Fan, Huahao Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention |
title | Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention |
title_full | Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention |
title_fullStr | Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention |
title_full_unstemmed | Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention |
title_short | Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention |
title_sort | sub‐lineages of the sars‐cov‐2 omicron variants: characteristics and prevention |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380698/ https://www.ncbi.nlm.nih.gov/pubmed/35992968 http://dx.doi.org/10.1002/mco2.172 |
work_keys_str_mv | AT xuailan sublineagesofthesarscov2omicronvariantscharacteristicsandprevention AT hongbixia sublineagesofthesarscov2omicronvariantscharacteristicsandprevention AT loufuxing sublineagesofthesarscov2omicronvariantscharacteristicsandprevention AT wangshuqi sublineagesofthesarscov2omicronvariantscharacteristicsandprevention AT liwenye sublineagesofthesarscov2omicronvariantscharacteristicsandprevention AT shafqatamna sublineagesofthesarscov2omicronvariantscharacteristicsandprevention AT anxiaoping sublineagesofthesarscov2omicronvariantscharacteristicsandprevention AT zhaoyunwei sublineagesofthesarscov2omicronvariantscharacteristicsandprevention AT songlihua sublineagesofthesarscov2omicronvariantscharacteristicsandprevention AT tongyigang sublineagesofthesarscov2omicronvariantscharacteristicsandprevention AT fanhuahao sublineagesofthesarscov2omicronvariantscharacteristicsandprevention |